RJFSA
HURA

Raymond James Financial Services Advisors’s TuHURA Biosciences HURA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed -$6K – 2932
2019
Q1 		$6K Hold
1
– – ﹤0.01% 2783
2018
Q4 		$4K Hold
1
– – ﹤0.01% 2556
2018
Q3 		$9K Hold
1
– – ﹤0.01% 2791
2018
Q2 		$9K Hold
1
– – ﹤0.01% 2753
2018
Q1 		$12K Hold
1
– – ﹤0.01% 2524
2017
Q4 		$14K Hold
1
– – ﹤0.01% 2510
2017
Q3 		$11K Sell
1
-6
-86% -$164K ﹤0.01% 2540
2017
Q2 		$294K Hold
7
– – ﹤0.01% 1998
2017
Q1 		$544K Hold
7
– – ﹤0.01% 1516
2016
Q4 		$413K Hold
7
– – ﹤0.01% 1628
2016
Q3 		$785K Buy
+7
New +$867K 0.01% 1233

Other funds holding HURA

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Raymond James Financial Services Advisors's HURA Position: Q2 2019 in Review

Raymond James Financial Services Advisors sold out of TuHURA Biosciences (HURA) in Q2 2019, closing a stake of 1 share — an estimated $6K sold.

Raymond James Financial Services Advisors first reported a position in HURA in Q3 2016 and held it in 11 quarters. The position peaked at $785K in Q3 2016. 2 funds tracked by Wall St. Rank hold HURA as of Q2 2019.

  • Raymond James Financial Services Advisors reported no remaining TuHURA Biosciences position as of Q2 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1 TuHURA Biosciences share in Q2 2019, an estimated $6K.
  • Raymond James Financial Services Advisors first reported a position in TuHURA Biosciences in Q3 2016 and held it in 11 quarters.
  • Raymond James Financial Services Advisors's TuHURA Biosciences position peaked at $785K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.